EarningsQ3 2024 Earnings Report

AbbVie (ABBV) Q3 2024 Earnings Report

0 Followers

MX:ABBV Q3 2024 EPS Results

Actual EPS$54.29

Consensus EPS$52.84

Beat/MissBeat by +$1.45

One Year Ago EPS$53.38

Actual Revenue$261.66B

Expected Revenue$258.44B

Beat/MissBeat by +$3.22B

YoY Revenue Growth+3.83%

QuarterQ3 2024

Date10/30/2024

TimeBefore Open

Conference CallWednesday, October 30, 2024

MX:ABBV Upcoming Earnings

AbbVie's next earnings date is estimated for October 23, 2026, based on past reporting schedules.

MX:ABBV Q3 2024 Earnings Call

0:00 / 0:00

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Oct 23, 2026	2026 (Q3)	69.83 / -	33.657	―
Jul 31, 2026	2026 (Q2)	65.23 / 66.05	53.743	22.90% (+12.30)
Apr 29, 2026	2026 (Q1)	46.90 / 47.95	44.514	7.72% (+3.44)
Feb 04, 2026	2025 (Q4)	48.01 / 49.04	39.086	25.46% (+9.95)
Oct 31, 2025	2025 (Q3)	31.96 / 33.66	54.286	-38.00% (-20.63)
Jul 31, 2025	2025 (Q2)	52.11 / 53.74	47.953	12.08% (+5.79)
Apr 25, 2025	2025 (Q1)	43.05 / 44.51	41.8	6.49% (+2.71)
Jan 31, 2025	2024 (Q4)	38.27 / 39.09	50.486	-22.58% (-11.40)
Oct 30, 2024	2024 (Q3)	52.84 / 54.29	53.381	1.69% (+0.90)
Jul 25, 2024	2024 (Q2)	46.43 / 47.95	52.657	-8.93% (-4.70)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed